Gilead Sciences, Inc. (GILD): who owns it and who trades it
As of Nov 16, 2026, GILD insiders reported 82 open-market sales worth $105M and no purchases in the last 12 months, with 99% of the sale value made under pre-set 10b5-1 plans. The largest seller was Daniel Patrick O'Day (CEO), with $76.3M. 7 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Gilead Sciences
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns GILD
2,263 funds and institutions reported GILD shares worth $141B at the end of Q2 2026, about 90% of the company. The largest holder is BlackRock, Inc. with 9.8%.
Funds and institutions (13F) 90%Everyone else 10%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 121.84M | 9.81% | $15.4B | +2% |
| Vanguard Capital Management LLC | 81.09M | 6.53% | $10.2B | +1% |
| FMR LLC (Fidelity) | 66.87M | 5.39% | $8.4B | -7% |
| State Street Corp | 61.22M | 4.93% | $7.7B | +2% |
| Capital World Investors | 40.99M | 3.30% | $5.2B | -1% |
| Invesco Ltd. | 39.82M | 3.21% | $5B | +156% |
| Vanguard Portfolio Management LLC | 35.32M | 2.84% | $4.5B | +1% |
| Geode Capital Management, LLC | 30.07M | 2.42% | $3.8B | +1% |
| T. Rowe Price Associates | 30.00M | 2.42% | $3.8B | +14% |
| Morgan Stanley | 24.00M | 1.93% | $3B | +3% |
| Dodge & Cox | 23.68M | 1.91% | $3B | -2% |
| Norges Bank | 21.97M | 1.77% | $2.8B | – |
| JPMorgan Chase & Co | 20.82M | 1.68% | $2.6B | – |
| Capital Research Global Investors | 19.39M | 1.56% | $2.5B | -29% |
| Bank of America Corp | 18.65M | 1.50% | $2.4B | -7% |
| Bank of New York Mellon Corp | 15.26M | 1.23% | $1.9B | +1% |
| Northern Trust Corp | 13.83M | 1.11% | $1.7B | +0% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 12.99M | 1.05% | $1.6B | -2% |
| Wellington Management Group LLP | 12.70M | 1.02% | $1.6B | -6% |
| Goldman Sachs Group Inc | 10.78M | 0.87% | $1.4B | -3% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, GILD insiders reported $0 of open-market purchases and $105M of sales. 99% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Kelly A. Kramer | Director | Sale plan | 1,676 | $168.23 | $282K | Form 4 |
| Nov 12, 2026 | Kelly A. Kramer | Director | Sale plan | 3,800 | $169.44 | $644K | Form 4 |
| Nov 12, 2026 | Kelly A. Kramer | Director | Sale plan | 4,700 | $170.49 | $801K | Form 4 |
| Nov 12, 2026 | Kelly A. Kramer | Director | Sale plan | 200 | $171.44 | $34.3K | Form 4 |
| Nov 6, 2026 | Wettan Keeley M Cain | Vice president | Sale plan | 3,399 | $164.11 | $558K | Form 4 |
| Nov 5, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 9,810 | $175.17 | $1.7M | Form 4 |
| Nov 4, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 102,619 | $175.16 | $18M | Form 4 |
| Nov 2, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 1,600 | $167.40 | $268K | Form 4 |
| Nov 2, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 1,700 | $168.10 | $286K | Form 4 |
| Nov 2, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 1,904 | $169.27 | $322K | Form 4 |
| Nov 2, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 7,796 | $170.35 | $1.3M | Form 4 |
| Nov 2, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 2,000 | $171.06 | $342K | Form 4 |
| Oct 30, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 15,881 | $175.25 | $2.8M | Form 4 |
| Oct 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $156.22 | $469K | Form 4 |
| Oct 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 12,000 | $147.72 | $1.8M | Form 4 |
| Oct 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 3,000 | $148.63 | $446K | Form 4 |
| Sep 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $145.29 | $436K | Form 4 |
| Sep 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 1,600 | $143.69 | $230K | Form 4 |
| Sep 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 800 | $144.46 | $116K | Form 4 |
| Sep 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 600 | $145.29 | $87.2K | Form 4 |
| Sep 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 1,600 | $147.51 | $236K | Form 4 |
| Sep 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 7,992 | $148.36 | $1.2M | Form 4 |
| Sep 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 5,408 | $149.38 | $808K | Form 4 |
| Aug 26, 2026 | Anthony Welters | Director | Sale plan | 4,600 | $148.82 | $685K | Form 4 |
| Aug 26, 2026 | Anthony Welters | Director | Sale plan | 6,880 | $148.82 | $1M | Form 4 |
| Aug 26, 2026 | Anthony Welters | Director | Sale plan | 3,402 | $148.24 | $504K | Form 4 |
| Aug 26, 2026 | Anthony Welters | Director | Sale plan | 3,118 | $148.31 | $462K | Form 4 |
| Aug 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 1,658 | $145.73 | $242K | Form 4 |
| Aug 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 1,816 | $144.92 | $263K | Form 4 |
| Aug 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 1,165 | $143.75 | $167K | Form 4 |
| Aug 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 335 | $146.26 | $49K | Form 4 |
| Aug 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 26 | $146.36 | $3.8K | Form 4 |
| Aug 17, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $138.36 | $415K | Form 4 |
| Aug 17, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 11,470 | $138.04 | $1.6M | Form 4 |
| Aug 17, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 16,530 | $137.37 | $2.3M | Form 4 |
| Aug 3, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 6,700 | $129.66 | $869K | Form 4 |
| Aug 3, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 600 | $131.34 | $78.8K | Form 4 |
| Aug 3, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 7,700 | $130.80 | $1M | Form 4 |
| Jul 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $129.93 | $390K | Form 4 |
| Jul 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 3,000 | $129.92 | $390K | Form 4 |
| Jul 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 11,900 | $126.09 | $1.5M | Form 4 |
| Jul 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 3,100 | $127.08 | $394K | Form 4 |
| Jun 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 1,480 | $123.42 | $183K | Form 4 |
| Jun 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 450 | $125.40 | $56.4K | Form 4 |
| Jun 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 1,070 | $124.00 | $133K | Form 4 |
| Jun 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $125.40 | $376K | Form 4 |
| Jun 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 10,900 | $131.10 | $1.4M | Form 4 |
| Jun 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 3,062 | $132.22 | $405K | Form 4 |
| Jun 1, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 1,038 | $132.97 | $138K | Form 4 |
| May 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $132.27 | $397K | Form 4 |
| May 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 700 | $132.75 | $92.9K | Form 4 |
| May 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 11,177 | $131.19 | $1.5M | Form 4 |
| May 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 8,374 | $132.23 | $1.1M | Form 4 |
| May 15, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 7,749 | $130.29 | $1M | Form 4 |
| Apr 28, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 3,050 | $130.01 | $397K | Form 4 |
| Apr 28, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 6,950 | $128.79 | $895K | Form 4 |
| Apr 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $140.96 | $423K | Form 4 |
| Mar 27, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 10,000 | $136.82 | $1.4M | Form 4 |
| Mar 16, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 3,000 | $144.23 | $433K | Form 4 |
| Feb 27, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 3,481 | $144.04 | $501K | Form 4 |
| Feb 27, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 6,419 | $145.18 | $932K | Form 4 |
| Feb 27, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 100 | $145.71 | $14.6K | Form 4 |
| Feb 17, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 18,405 | $154.18 | $2.8M | Form 4 |
| Feb 17, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 9,395 | $154.91 | $1.5M | Form 4 |
| Feb 17, 2026 | Johanna Mercier | Chief Comm & Corp Aff Of | Sale plan | 200 | $155.62 | $31.1K | Form 4 |
| Feb 17, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $154.43 | $463K | Form 4 |
| Feb 5, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 115,640 | $150.00 | $17.3M | Form 4 |
| Jan 28, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 4,968 | $140.24 | $697K | Form 4 |
| Jan 28, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 5,032 | $139.54 | $702K | Form 4 |
| Jan 23, 2026 | Daniel Patrick O'Day | CEO | Sale plan | 115,640 | $135.00 | $15.6M | Form 4 |
| Jan 20, 2026 | Jeffrey Bluestone | Director | Sale plan | 5,000 | $123.50 | $618K | Form 4 |
| Jan 15, 2026 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $124.31 | $373K | Form 4 |
| Dec 29, 2025 | Daniel Patrick O'Day | CEO | Sale plan | 10,000 | $124.83 | $1.2M | Form 4 |
| Dec 15, 2025 | Andrew D Dickinson | CFO | Sale plan | 3,000 | $122.00 | $366K | Form 4 |
| Nov 28, 2025 | Jeffrey Bluestone | Director | Sale | 5,000 | $125.08 | $625K | Form 4 |
| Nov 28, 2025 | Kelly A. Kramer | Director | Sale plan | 2,805 | $127.10 | $357K | Form 4 |
| Nov 28, 2025 | Daniel Patrick O'Day | CEO | Sale plan | 6,788 | $126.84 | $861K | Form 4 |
| Nov 28, 2025 | Daniel Patrick O'Day | CEO | Sale plan | 3,212 | $125.91 | $404K | Form 4 |
| Nov 26, 2025 | Kelly A. Kramer | Director | Sale plan | 2,806 | $127.11 | $357K | Form 4 |
| Nov 17, 2025 | Andrew D Dickinson | CFO | Sale plan | 2,500 | $125.23 | $313K | Form 4 |
| Nov 17, 2025 | Johanna Mercier | Chief Commercial Officer | Sale plan | 2,476 | $126.26 | $313K | Form 4 |
| Nov 17, 2025 | Johanna Mercier | Chief Commercial Officer | Sale plan | 25,524 | $125.83 | $3.2M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Daniel Patrick O'Day | Chairman & CEO, Director | – | $76.3M | Nov 5, 2026 |
| Johanna Mercier | Chief Commercial Officer | – | $17M | Sep 15, 2026 |
| Andrew D Dickinson | Chief Financial Officer | – | $4.4M | Oct 15, 2026 |
| Anthony Welters | Director | – | $2.7M | Aug 26, 2026 |
| Kelly A. Kramer | Director | – | $2.5M | Nov 12, 2026 |
| Jeffrey Bluestone | Director | – | $2M | Aug 20, 2026 |
| Wettan Keeley M Cain | EVP Gen Counsel, Legal & Comp | – | $558K | Nov 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
GILD short interest
Low short interest. 1.7% of GILD shares are sold short: about 1 share in 58. Over the last 12 reports the number of shares short went down 8%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 21.27M GILD shares were sold short, 1.7% of the shares outstanding, up 4.9% from the report before. At the average daily volume of 6.70M shares, buying them all back would take about 3.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 21.27M | 1.72% | +5% | 6.70M | 3.2 |
| Oct 15, 2026 | 20.27M | 1.63% | -7% | 5.45M | 3.7 |
| Sep 30, 2026 | 21.83M | 1.76% | +19% | 6.50M | 3.4 |
| Sep 15, 2026 | 18.30M | 1.48% | -20% | 5.02M | 3.6 |
| Aug 31, 2026 | 23.01M | 1.86% | -1% | 5.44M | 4.2 |
| Aug 14, 2026 | 23.18M | 1.87% | -5% | 7.15M | 3.2 |
| Jul 31, 2026 | 24.39M | 1.97% | -3% | 6.31M | 3.9 |
| Jul 15, 2026 | 25.26M | 2.03% | -1% | 6.89M | 3.7 |
| Jun 30, 2026 | 25.48M | 2.05% | +7% | 9.60M | 2.7 |
| Jun 15, 2026 | 23.86M | 1.92% | -7% | 8.87M | 2.7 |
| May 29, 2026 | 25.73M | 2.07% | +11% | 6.74M | 3.8 |
| May 15, 2026 | 23.14M | 1.86% | +0% | 6.50M | 3.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded GILD
Since Nov 17, 2024, 8 members of Congress reported 9 purchases and 4 sales of GILD. The latest was a purchase by Jared Moskowitz on May 6, 2026, reported Jun 19, 2026.
Purchases 9Sales 4
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| May 6, 2026 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Child | Jun 19, 2026 | Report |
| May 6, 2026 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Self | Jun 19, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Jan 27, 2026 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | Feb 26, 2026 | Report |
| Sep 23, 2025 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Oct 10, 2025 | Report |
| Jun 6, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | Jun 18, 2025 | Report |
| May 14, 2025 | Josh Gottheimer (D-NJ) | Sale | $1K–$15K | Joint | Jun 11, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| May 5, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | May 6, 2025 | Report |
| Apr 16, 2025 | John Boozman (R-AR) | Sale | $1K–$15K | Joint | May 14, 2025 | Report |
| Mar 31, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | Apr 11, 2025 | Report |
| Mar 10, 2025 | Carol D. Miller (R-WV) | Purchase | $1K–$15K | Self | Apr 11, 2025 | Report |
| Mar 7, 2025 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | Apr 10, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Gilead Sciences company events
Gilead Sciences filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- May 20, 2026AgreementGilead Sciences, Inc. and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as trustee, entered into an Eleventh Supplemental Indenture to the Indenture between the Parties, dated as of March 30, 2011. Filing
- May 7, 2026ResultsReleased financial results. Filing
- May 4, 2026VoteReported shareholder vote results. Filing
- Apr 28, 2026AnnouncementAs previously disclosed, on February 22, 2026, Gilead entered into an Agreement and Plan of Merger, among Parent, the Company and Ravens Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent. Filing
- Feb 23, 2026AgreementGilead Sciences, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger, among Parent, Arcellx, Inc., a Delaware corporation, and Ravens Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent. Filing
- Feb 10, 2026ResultsReleased financial results. Filing
- Nov 19, 2025LeadershipOn November 19, 2025, Gilead Sciences, Inc., a Delaware corporation, announced that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel of the Company as of December 5, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Gilead Sciences makes money
Biktarvy (HIV) brought in half of Gilead Sciences's revenue ($14.3B of $29.4B) in 2025. Cell therapy was next, at 6%.
By product or service, 2025
By region, 2025
From Gilead Sciences's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 24, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Gilead Sciences financials
Famous investors that hold GILD
7 of the 50 well-known investors we track reported holding GILD in their latest 13F filing. The largest position is Jim Simons's, worth $306M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 2.05M | $306M | 0.4% | -7% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.73M | $258M | 0.1% | -50% |
| Israel Englander · Millennium Management | Q3 2026 | 1.63M | $243M | 0.2% | +12% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 564,443 | $84.1M | 0.4% | +654% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 321,419 | $47.9M | 0.2% | +10% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 305,850 | $45.6M | 0.0% | +1516% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 3,256 | $485K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Gilead Sciences, Inc. (GILD) stock
Who owns the most GILD stock?
The largest reported owner of Gilead Sciences, Inc. (GILD) is BlackRock, Inc., with 9.8% of the company. In total, 2,263 funds and institutions reported holding GILD at the end of Q2 2026, together about 90% of the shares. See the largest owners.
Are GILD insiders buying or selling?
In the last 12 months, GILD insiders reported no open-market purchases and 82 sales worth $105M. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in GILD?
As of Oct 30, 2026, 21.27M GILD shares were sold short, 1.7% of the shares outstanding, up 4.9% from the report before. At the average daily volume of 6.70M shares, buying them all back would take about 3.2 trading days (days to cover). See the history.
Have members of Congress traded GILD?
Yes. 8 members of Congress reported 9 purchases and 4 sales of GILD since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
How does Gilead Sciences make money?
Biktarvy (HIV) brought in half of Gilead Sciences's revenue ($14.3B of $29.4B) in 2025. Cell therapy was next, at 6%. See the full split.
Which famous investors hold GILD?
7 of the 50 well-known investors we track reported GILD in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $306M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.